Pluronic L61 As A Long-Circulating Modifier for Enhanced Liposomal Delivery of Cancer Drugs

Ye Wang,Ergang Liu,Xiaoyi Sun,Pengyu Huang,Hao Long,Hua Wang,Xin Yu,Caihong Zheng,Yongzhuo Huang
DOI: https://doi.org/10.1039/c3py00042g
IF: 4.6
2013-01-01
Polymer Chemistry
Abstract:Pluronic copolymer L61 was found to possess a stealth function for liposomal drug delivery, comparing favorably to PEG. The liposomes modified with 0.1% L61 (w/w) were long-circulating, and preferentially accumulated in the tumor site. The paclitaxel-loaded L61-liposomes with a single injection dose could successfully arrest the tumor growth, lasting for five days, and displayed better treatment outcomes compared to the non-modified liposomes and even the PEGylated liposomes.
What problem does this paper attempt to address?